Literature DB >> 15608000

Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections.

N W S Davies1, L J Brown, J Gonde, D Irish, R O Robinson, A V Swan, J Banatvala, R S Howard, M K Sharief, P Muir.   

Abstract

BACKGROUND: Polymerase chain reaction (PCR) is used to detect viruses in the cerebrospinal fluid (CSF) of patients with neurological disease. However, data to assist its use or interpretation are limited.
OBJECTIVE: We investigated factors possibly influencing viral detection in CSF by PCR, which will also help clinicians interpret positive and negative results.
METHODS: CSF from patients with was tested for human herpesviruses types 1-6, JC virus, enteroviruses, and Toxoplasma gondii. The likelihood of central nervous system (CNS) infection was classified as likely, possible, or unlikely. PCR findings in these categories were compared using single variable and logistic regression analysis.
RESULTS: Of 787 samples tested, 97 (12%) were PCR positive for one or more viruses. Of episodes likely to be CNS viral infections, 30% were PCR positive compared to 5% categorised as unlikely. The most frequent positive findings were Epstein Barr virus (EBV), enteroviruses, and herpes simplex virus (HSV). Enteroviruses and HSV were found predominantly in the likely CNS viral infection group, whereas EBV was found mainly in the unlikely group. Positive PCR results were more likely when there were 3-14 days between symptom onset and lumbar puncture, and when CSF white cell count was abnormal, although a normal CSF did not exclude a viral infection.
CONCLUSIONS: The diagnostic yield of PCR can be maximised by using sensitive assays to detect a range of pathogens in appropriately timed CSF samples. PCR results, in particular EBV, should be interpreted cautiously when symptoms cannot readily be attributed to the virus detected.

Entities:  

Mesh:

Year:  2005        PMID: 15608000      PMCID: PMC1739313          DOI: 10.1136/jnnp.2004.045336

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

Review 1.  Polymerase chain reaction in the diagnosis and management of central nervous system infections.

Authors:  R L DeBiasi; K L Tyler
Journal:  Arch Neurol       Date:  1999-10

Review 2.  Specific diagnostic methods for herpesvirus infections of the central nervous system: a consensus review by the European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  A Linde; P E Klapper; P Monteyne; J M Echevarria; P Cinque; F Rozenberg; B F Vestergaard; M Ciardi; P Lebon; G M Cleator
Journal:  Clin Diagn Virol       Date:  1997-08

3.  Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples.

Authors:  R B Domingues; A M Tsanaclis; C S Pannuti; M S Mayo; F D Lakeman
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

Review 4.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

5.  Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations.

Authors:  T Bergström
Journal:  Scand J Infect Dis Suppl       Date:  1996

6.  Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results.

Authors:  K J Jeffery; S J Read; T E Peto; R T Mayon-White; C R Bangham
Journal:  Lancet       Date:  1997-02-01       Impact factor: 79.321

7.  Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authors:  F D Lakeman; R J Whitley
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

8.  Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

Authors:  P Cinque; M Brytting; L Vago; A Castagna; C Parravicini; N Zanchetta; A D'Arminio Monforte; B Wahren; A Lazzarin; A Linde
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

9.  Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction.

Authors:  T Weber; R W Turner; S Frye; B Ruf; J Haas; E Schielke; H D Pohle; W Lüke; W Lüer; K Felgenhauer
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

10.  Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction.

Authors:  Y Schlesinger; P Tebas; M Gaudreault-Keener; R S Buller; G A Storch
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

View more
  33 in total

1.  Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.

Authors:  Katherine N Ward; Hoe Nam Leong; Anton D Thiruchelvam; Claire E Atkinson; Duncan A Clark
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

2.  Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England.

Authors:  H E Ambrose; J Granerod; J P Clewley; N W S Davies; G Keir; R Cunningham; M Zuckerman; K J Mutton; K N Ward; S Ijaz; N S Crowcroft; D W G Brown
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

3.  Infectious encephalitis: utility of a rational approach to aetiological diagnosis in daily clinical practice.

Authors:  C López-Sánchez; E Sulleiro; C Bocanegra; S Romero; G Codina; I Sanz; J Esperalba; J Serra; C Pigrau; J Burgos; B Almirante; V Falcó
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-25       Impact factor: 3.267

4.  Prevalence of herpes simplex virus (types 1 and 2), varicella-zoster virus, cytomegalovirus, and human herpesvirus 6 and 7 DNA in cerebrospinal fluid of Middle Eastern patients with encephalitis.

Authors:  Ali I Ibrahim; Michel T Obeid; Muhidien J Jouma; Klaus Roemer; Nikolaus Mueller-Lantzsch; Barbara C Gärtner
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands.

Authors:  Gijsbert P van Nierop; Rogier Q Hintzen; Georges M G M Verjans
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

6.  High-dose corticosteroids for acute cytomegalovirus-associated transverse myelitis in the immunocompetent patient: a case report and systematic review.

Authors:  A Budhram; Y Liu; M Krawczyk; T L H Chan; J G Burneo; S M Hosseini-Moghaddam; C Shoesmith
Journal:  J Neurovirol       Date:  2019-01-04       Impact factor: 2.643

7.  Classification of genes and putative biomarker identification using distribution metrics on expression profiles.

Authors:  Hung-Chung Huang; Daniel Jupiter; Vincent VanBuren
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

8.  Post-malaria neurological syndrome or viral encephalitis?

Authors:  André Caetano; Marcelo D Mendonça; Nuno Ribeiro Ferreira; Luísa Alves
Journal:  BMJ Case Rep       Date:  2016-01-07

Review 9.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

10.  Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis.

Authors:  Thomas W Harper; Darlene Miller; Joyce C Schiffman; Janet L Davis
Journal:  Am J Ophthalmol       Date:  2008-10-02       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.